1-16 of 16
Sara E. Meyer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Distinct Cell-Intrinsic and Extrinsic Consequences of TLR2 Activation Drive Pleiotropic Effects in AML Affecting Overall Survival

Michael E Lawler, Jennifer Romer-Seibert, Michael S Bowman, Ramkrishna Mitra, Christine Eischen, Robert L. Bowman, Sara E. Meyer
Journal: Blood
Blood (2024) 144 (Supplement 1): 1343.
https://doi.org/10.1182/blood-2024-211594
Published: 2024
Journal Articles

A Phase Ib/II Study Evaluating Navitoclax after Failure of Hypomethylating Agent and Venetoclax for Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome

Gina Keiffer, Sara E. Meyer, Christine Eischen, Ubaldo Martinez Outschoorn, Onder Alpdogan, Adam F. Binder, Pierluigi Porcu, Lindsay Wilde, Margaret Kasner, Neil Palmisiano
Journal: Blood
Blood (2023) 142 (Supplement 1): 1551.
https://doi.org/10.1182/blood-2023-186765
Published: 2023
Journal Articles

Context is key for FLT3-ITD

Sara E. Meyer
Journal: Blood
Blood (2023) 141 (12): 1373–1374.
https://doi.org/10.1182/blood.2022019135
Published: 2023
Journal Articles

FLT3 Inhibition Downregulates EZH2 in AML and Promotes Myeloid Differentiation

Pamela J. Sung, Simone Sidoli, Simone S. Riedel, Katarzyna Kulej, Hongbo Xie, Bryan Manning, Daniel Tsai, Gerald Wertheim, Benjamin A. Garcia, Sara E. Meyer, Kathrin M. Bernt, Martin P. Carroll
Journal: Blood
Blood (2021) 138 (Supplement 1): 785.
https://doi.org/10.1182/blood-2021-147313
Published: 2021
Journal Articles

Clonotype-Immunophenotype Relationships in TET2 and IDH -Mutant Myeloid Transformation

Linde A. Miles, Robert L. Bowman, Nicole Delgaudio, Troy Robinson, Martin P. Carroll, Sara E. Meyer, Ross L. Levine
Journal: Blood
Blood (2021) 138 (Supplement 1): 373.
https://doi.org/10.1182/blood-2021-151819
Published: 2021
Journal Articles

MicroRNA immunomodulating therapeutics

Sara E. Meyer
Journal: Blood
Blood (2020) 135 (3): 155–156.
https://doi.org/10.1182/blood.2019004106
Published: 2020
Journal Articles

Single Cell DNA Sequencing Identifies Combinatorial Mutation Patterns and Clonal Architecture in Myeloid Malignancies

Linde A Miles, PhD, Robert L Bowman, PhD, Tiffany R Merlinsky, Aik Ooi, PhD, Pedro Mendez, Christopher Famulare, MS, Minal A Patel, MPH, Kelly Bolton, MD PhD, Neil Palmisiano, MD MS, Martin P. Carroll, MD, Elli Papaemmanuil, PhD, Ahmet Zehir, PhD, Sara E. Meyer, PhD, Aaron D Viny, MDMS, Ross L. Levine, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 913.
https://doi.org/10.1182/blood-2019-128763
Published: 2019
Journal Articles

Splicing together the origins of MDS-RS

Sara E. Meyer
Journal: Blood
Blood (2017) 130 (7): 841–842.
https://doi.org/10.1182/blood-2017-07-793075
Published: 2017
Journal Articles

From EMT to HSC to AML: ZEB2 is a cell fate switch

Sara E. Meyer
Journal: Blood
Blood (2017) 129 (4): 400–401.
https://doi.org/10.1182/blood-2016-11-748186
Published: 2017
Journal Articles

Balancing Proliferation, Differentiation, and Survival: Powerful Genetic and RNAi Technologies Reveal Essential microRNA Signaling for Leukemic Progenitor Cell Fitness

Sara E. Meyer, PhD, Emily Orr, Andrew M. Rogers, MS,MD, John G Doench, PhD, Bruce J. Aronow, PhD, Ashish Lal, PhD, Edwina McGlinn, PhD, H. Leighton Grimes, PhD
Journal: Blood
Blood (2015) 126 (23): 441.
https://doi.org/10.1182/blood.V126.23.441.441
Published: 2015
Journal Articles

Transcriptional Control of HSC Fitness

David E. Muench, MEng, Chinavenmeni S. Velu, PhD, Andre Olsson, PhD, Sara E. Meyer, PhD, H. Leighton Grimes, PhD
Journal: Blood
Blood (2015) 126 (23): 1161.
https://doi.org/10.1182/blood.V126.23.1161.1161
Published: 2015
Journal Articles

A 2-way miRror of red blood cells and leukemia

H. Leighton Grimes, Sara E. Meyer
Journal: Blood
Blood (2015) 125 (8): 1202–1203.
https://doi.org/10.1182/blood-2015-01-618975
Published: 2015
Journal Articles

Functional Screening Of Oncomir-196b-RISC Captured Targets Reveal Mir-Inhibition Of Tumor Suppressor Activity In MLL-AF9 Mediated Leukemogenesis

Sara E. Meyer, PhD, Rogers M. Andrew, MS, Bruce J Aronow, PhD, Kakajan Komurov, PhD, Ashish Lal, PhD, Judy Lieberman, MD, PhD, H. Leighton Grimes, PhD
Journal: Blood
Blood (2013) 122 (21): 475.
https://doi.org/10.1182/blood.V122.21.475.475
Published: 2013
Journal Articles

The human GFI136N variant induces epigenetic changes at the Hoxa9 locus and accelerates K-RAS driven myeloproliferative disorder in mice

Cyrus Khandanpour, Joseph Krongold, Judith Schütte, Frederique Bouwman, Lothar Vassen, Marie-Claude Gaudreau, Riyan Chen, Fernando J. Calero-Nieto, Evangelia Diamanti, Rebecca Hannah, Sara E. Meyer, H. Leighton Grimes, Bert A. van der Reijden, Joop H. Jansen, Chandrashekhar V. Patel, Justine K. Peeters, Bob Löwenberg, Ulrich Dührsen, Bertie Göttgens, Tarik Möröy
Journal: Blood
Blood (2012) 120 (19): 4006–4017.
https://doi.org/10.1182/blood-2011-02-334722
Published: 2012
Includes: Supplemental data
Journal Articles

Unbiased Analyses of Signaling Through Leukemia Associated MicroRNA

Sara E. Meyer, PhD, Andrew M. Rogers, MS, Ashish Lal, PhD, Judy Lieberman, MD, PhD, Bruce J Aronow, PhD, Kakajan Komurov, PhD, H. Leighton Grimes, PhD
Journal: Blood
Blood (2011) 118 (21): 2373.
https://doi.org/10.1182/blood.V118.21.2373.2373
Published: 2011
Journal Articles

The Growth Factor Independence 1 variant form GFI136N Predisposes to Acute Myeloid Leukemia by Inducing Epigenetic Changes in Oncogenes Such As Hoxa9

Cyrus Khandanpour, MD, Joseph Krongold, BSc,, Judith Schütte, Frederique Bouwman, Lothar Vassen, PhD, Marie-Claude Gaudreau, M.Sc., Riyan Chen, PhD., Sara E. Meyer, PhD, H. Leighton Grimes, PhD, Bert A. Van der Reijden, PhD, Joop H. Jansen, PhD, Bob Lowenberg, MD, PhD, Justine K Peeters, Patel Chandrashekhar, Ulrich Duehrsen, MD, Berthold Goettgens, PhD., Tarik Moroy, Ph.D.
Journal: Blood
Blood (2011) 118 (21): 223.
https://doi.org/10.1182/blood.V118.21.223.223
Published: 2011